Skip to content

3D printed skin for diabetic wound healing

USE OF 3D PRINTED SKIN AS SKIN GRAFT IN CHRONIC NON-HEALING ULCERS - NIL

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/11/076815
Enrollment
26
Registered
2024-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2024-12-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E118- Type 2 diabetes mellitus with unspecified complications

Interventions

Intervention1: 3D printed skin: It is made up of xenogenic skin, polymerized with PVA to form a bioink. It has extracellular matrix which attracts cells and accelerate wound healing. The skin graft wi

Sponsors

Dr Vaishali Gaikwad
Lead Sponsor
Dr Meghnad Ganesh Joshi
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: The 3D-printed skin grafts are made up of xenogenic skin composed of extracellular matrix. This graft will be sterilized and used on the wounded area as a treatment.

Exclusion criteria

Exclusion criteria: All the patients who do not follow up in OPD. Patients with diabetic foot ulcers undergoing amputation. Patients with immunocompromised status. Patients with osteomyelitis or gangrenous ulcers. All the patients who do not give consent for the study.

Design outcomes

Primary

MeasureTime frame
The primary outcome of the study will be : 1. Acceptance of the skin graft 2. Wound healing rate 3. Incidence of wound closureTimepoint: 4 to 8 weeks

Secondary

MeasureTime frame
Safety & Tolerability Quality of Wound Healing Assessment of scar Pain Reduction Patient Satisfaction & Quality of Life Cost-effectivenessTimepoint: 7-8 weeks

Countries

India

Contacts

Public ContactDr Manchikalapudi Sujitha

Dr. D. Y. Patil Medical College, Hospital and Research Centre, Kadamwadi, Kolhapur

drvaishaligaikwad@gmail.com9822379069

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026